全文获取类型
收费全文 | 16292篇 |
免费 | 862篇 |
国内免费 | 125篇 |
专业分类
耳鼻咽喉 | 151篇 |
儿科学 | 327篇 |
妇产科学 | 352篇 |
基础医学 | 1917篇 |
口腔科学 | 393篇 |
临床医学 | 1238篇 |
内科学 | 5096篇 |
皮肤病学 | 419篇 |
神经病学 | 1285篇 |
特种医学 | 291篇 |
外科学 | 2255篇 |
综合类 | 96篇 |
一般理论 | 8篇 |
预防医学 | 1065篇 |
眼科学 | 300篇 |
药学 | 896篇 |
中国医学 | 37篇 |
肿瘤学 | 1153篇 |
出版年
2024年 | 13篇 |
2023年 | 137篇 |
2022年 | 307篇 |
2021年 | 704篇 |
2020年 | 311篇 |
2019年 | 632篇 |
2018年 | 690篇 |
2017年 | 407篇 |
2016年 | 422篇 |
2015年 | 452篇 |
2014年 | 739篇 |
2013年 | 812篇 |
2012年 | 1476篇 |
2011年 | 1491篇 |
2010年 | 776篇 |
2009年 | 694篇 |
2008年 | 1107篇 |
2007年 | 1110篇 |
2006年 | 958篇 |
2005年 | 921篇 |
2004年 | 842篇 |
2003年 | 681篇 |
2002年 | 693篇 |
2001年 | 84篇 |
2000年 | 67篇 |
1999年 | 85篇 |
1998年 | 104篇 |
1997年 | 98篇 |
1996年 | 71篇 |
1995年 | 45篇 |
1994年 | 49篇 |
1993年 | 39篇 |
1992年 | 27篇 |
1991年 | 23篇 |
1990年 | 20篇 |
1989年 | 15篇 |
1988年 | 15篇 |
1987年 | 11篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 11篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1976年 | 5篇 |
1975年 | 12篇 |
1971年 | 9篇 |
1970年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
11.
Aureli Torné Alfonso Alba Xavier Castellsagué Javier Cortés 《Progresos de Obstetricia y Ginecología》2006
Persistent infection by human papilloma virus (HPV) is considered to be the main cause of cervical cancer and other ano-genital cancers. Of more than 30 genotypes able to infect the anogenital tract, it is estimated that, worldwide, HPV 16 and 18 cause 70% of cervical cancers and that HPV 6 and 11 cause more than 90% of genital warts. In the last few years, the morbidity and mortality and health costs associated with cervical cancer and its precursor lesions have stimulated intense research activity to achieve primary prevention of this disease through prophylactic vaccines. 相似文献
12.
13.
14.
15.
This study presents the case of a patient with necrobiosis or necrosing fascitis of the inguinal region, secondary to a complicated
Amyand’s hernia with a concomitant ipsilateral Richter’s hernia. The patient was treated with open trans-abdominal surgery
and hernia repair through the pre-peritoneal approach, plus anti-microbians, and thrice-daily wound cleansing and dressings
to the inguinal region. Evolution was satisfactory. There are no reports in the literature of a case such as this. 相似文献
16.
17.
18.
Javier Garzón Almudena López-Fando Pilar Sánchez-Blázquez 《Neuropsychopharmacology》2003,28(11):1983-1990
Members of the R7 subfamily of regulators of G-protein signaling (RGS) proteins (RGS6, RGS7, RGS9-2, and RGS11) are found in the mouse CNS. The expression of these proteins was effectively reduced in different neural structures by blocking their mRNA with antisense oligodeoxynucleotides (ODNs). This was achieved without noticeable changes in the binding characteristics of labeled beta-endorphin to opioid receptors. Knockdown of R7 proteins enhanced the potency of antinociception promoted by morphine and [D-Ala(2), N-MePhe(4), Gly-ol(5)]-enkephalin (DAMGO)-both agonists at mu-opioid receptors. The duration of morphine analgesia was greatly increased in RGS9-2 and in RGS11 knockdown mice. The impairment of R7 proteins brought about different changes in the analgesic activity of selective delta agonists. Knockdown of RGS11 reduced [D-Ala(2)]deltorphin II analgesic effects. Those of RGS6 and RGS9-2 proteins caused [D-Ala(2)]deltorphin II to produce a smoothened time-course curve-the peak effect blunted and analgesia extended during the declining phase. RGS9-2 impairment also promoted a similar pattern of change for [D-Pen(2,5)]-enkephalin (DPDPE). RGS7-deficient mice showed an increased response to both [D-Ala(2)]deltorphin II and DPDPE analgesic effects. A single intracerebroventricular (i.c.v.) ED(80) analgesic dose of morphine gave rise to acute tolerance in control mice, but did not promote tolerance in RGS6, RGS7, RGS9-2, or RGS11 knockdown animals. Thus, R7 proteins play a critical role in agonist tachyphylaxis and acute tolerance at mu-opioid receptors, and show differences in their modulation of delta-opioid receptors. 相似文献
19.
Javier Alegre-López José Cordero-Guevara José L. Alonso-Valdivielso Julia Fernández-Melón 《Osteoporosis international》2005,16(7):729-736
Hip fracture results in excess mortality and functional disability. This study sought to identify predictors of mortality and limited functional ability 1 year after hip fracture. We conducted a 1-year follow-up of a prospective population-based inception cohort of 218 hip fracture patients who had been consecutively admitted and discharged from hospital during the previous year. Mortality was observed to be independently associated with poor mental status (relative risk [RR]=6.96; 95% confidence interval [95% CI], 1.73–28.00), prefracture limited functional ability (RR=4.35; 95% CI, 1.32–14.36), institutionalized disposition at discharge (RR=2.92; 95% CI, 1.02–8.38), and male gender (RR=2.44; 95% CI, 1.01–5.93). Independent predictors of limited functional ability were prefracture functional disability (RR=34.14; 95% CI, 3.13–372.33), poor mental status (RR=9.71; 95% CI, 1.57–59.82), age >80 years (RR=4.03; 95% CI, 1.48–11.00), and female gender (RR=3.57; 95% CI, 0.08–0.98). On discharge, special attention and care should thus be given to all patients displaying any of the above predictive factors. 相似文献
20.
David Jiménez Castro Gema Díaz David Martí Carlos Escobar Javier Ortega Sergio García-Rull Joaquin Picher Antonio Sueiro 《Blood coagulation & fibrinolysis》2007,18(2):173-177
This study aimed to determine whether a weight-adjusted dose of subcutaneous enoxaparin is as effective and safe as oral acenocoumarol for the secondary prophylaxis of pulmonary embolism. Three hundred and eighty consecutive noncancer outpatients hospitalized with an episode of symptomatic pulmonary embolism selected treatment with acenocoumarol or enoxaparin at a dose of 1 mg/kg once daily after being informed of the type of administration and expected frequency of laboratory monitoring for both medicinal products. Endpoints were symptomatic recurrent thromboembolic events evaluated by standard objective testing, and a composite endpoint of recurrent venous thromboembolism, major bleeding, and death from any cause. One hundred and ninety-nine patients (52%) chose acenocoumarol therapy and 181 chose enoxaparin monotherapy. Four patients in the enoxaparin group (2.2%) and six patients in the acenocoumarol group (3%) had an objective thromboembolic recurrence (hazard ratio, 1.35; 95% confidence interval, 0.38-4.79; P = 0.64). Nine patients in the enoxaparin group (5.0%) had a hemorrhagic complication compared with 11 in the acenocoumarol group (5.5%) (P = 0.81). The hospital length of stay was shorter with enoxaparin compared with acenocoumarol (11 versus 16 days, P = 0.0001). Enoxaparin is as effective and safe as acenocoumarol in the secondary prevention of recurrent thromboembolic disease and is associated with shorter hospitalization. 相似文献